Table 2 Results from two-part regressions and GLMs for costs (2023 US$)
PBT | CRT | |||||
|---|---|---|---|---|---|---|
First part | Second part | First part | Second part | Difference in cost over 58 weeks | ||
Parameters | % positive expenditure, mean (95% CI) | Cost, mean (95% CI) | % positive expenditure, mean (95% CI) | Cost, mean (95% CI) | Cost, mean (95% CI) | p-value |
Medication costs | 0.85 (0.80–0.90) | 3,206 (1,519–4,893) | 0.79 (0.66–0.92) | 2,686 (-451–5,825) | 528 (-3,453–4,510) | 0.795 |
Inpatient care costs | 0.29 (0.22–0.36) | 5,087 (3,005–7,168) | 0.32 (0.17–0.46) | 3,176 (968–5,393) | 2,227 (-1,986–6,440) | 0.330 |
Outpatient care costs | NA | 6,346 (5,634–7,058) | NA | 7,445 (5,926–8,964) | -1,099 (-2,777–578) | 0.199 |
Total healthcare costs | NA | 14,639 (11,829 − 17,449) | NA | 13,308 (8,111 − 18,505) | 1,372 (-4,914–7,659) | 0.669 |